Dedicated to Discovering Breakthroughs for Complicated Diseases

Clinical Trials

Clinical trials are vital to driving innovation and advancing science that improves patient lives.
Learn more about SalubrisBio’s clinical trials and how to participate.

JK07 in HFrEF

Our Phase 1 Trial is ongoing to evaluate JK07, a HER3-NRG1 antibody fusion protein, in NYHA II/III heart failure patients with reduced ejection fraction.

JK07 in HFpEF

Our Phase 1 Trial will evaluate JK07, a HER3-NRG1 antibody fusion protein, in NYHA II/III heart failure patients with preserved ejection fraction.

Solid Tumor Cancers

We will evaluate JK08, an immunocytokine fusion protein, in adults with solid tumors. Check back soon for more details.